| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Bornstein Jeffrey S serves as a Director at EOSE and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 3 buys and 6 sells. Those positions are worth an estimated $788K at current prices.
Historically, Bornstein Jeffrey S's trades have earned a below-average insider score of 38/100 across 6 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -38.3%.
The biggest single holding is EOSE (~$788K) as Director. The recent filings there lean toward selling, a net 183,048 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | EOSE Eos Energy Enterprises, Inc. | Director | Sell | 40,328 | $15.19 | $612,536.40 | -100% | -55.2% | - | |
| Sep 12, 2024 | EOSE Eos Energy Enterprises, Inc. | Director | Sell | 162,720 | $2.63 | $427,653.60 | -65.7% | +21.5% | +209.4% | |
| Nov 10, 2022 | EOSE Eos Energy Enterprises, Inc. | Director | Buy | 20,000 | $1.30 | $25,936.00 | New | +4.7% | -0.8% | |
| Apr 26, 2022 | KLRS Kalaris Therapeutics, Inc. | Director | Buy | 5,000 | $4.64 | $23,196.50 | +14.2% | -1.5% | -25.3% | |
| Feb 10, 2022 | KLRS Kalaris Therapeutics, Inc. | Director | Buy | 5,000 | $8.87 | $44,350.00 | +16.6% | -61.5% | -27.1% | |
| Feb 18, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 20,583 | $40.43 | $832,118.83 | -100% | - | - |